Artivion Inc (NYSE:AORT)
$ 27.73 -1.14 (-3.95%) Market Cap: 1.16 Bil Enterprise Value: 1.52 Bil PE Ratio: 0 PB Ratio: 3.81 GF Score: 77/100

Artivion Inc at Canaccord Genuity Growth Conference Transcript

Aug 09, 2023 / 04:00PM GMT
Release Date Price: $16.56 (-1.37%)
Bill Plovanic
Canaccord Genuity Group Inc. - Analyst

All right. Good afternoon. My name is Bill Plovanic. I'm a Senior Med Device Analyst here with Canaccord Genuity, and welcome to our 43rd Annual Global Growth Conference.

With me today is Pat Mackin, CEO; and Ashley Lee, CFO. The format today is going to be a presentation. We'll have a little time afterwards for Q&A. Happy to take questions from the audience. And with that, I just hand the podium over to Pat.

Pat Mackin
Artivion, Inc. - Chairman, President & CEO

Thanks, Bill, and good afternoon, everybody. So I'm Pat Mackin, and I'm the CEO of Artivion, and I'm pleased to present to you today.

Here's our forward-looking statement. You can find this on our web page, so I'm not going to read through it. Bill and I were just talking that people say who's Artivion?

And we're formerly CryoLife, and we rebranded about a 1.5 year ago. And I think you'll see why at the end of the presentation why we rebranded. And really, Artivion, our new name reflects our focus on the aorta

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot